La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Cardinal Health Gestione

Gestione criteri di controllo 2/4

Cardinal Health's Il CEO è Jason Hollar, nominato in Sep2022, e ha un mandato di 1.92 anni. la retribuzione annua totale è $ 18.78M, composta da 6.6% di stipendio e 93.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.04% delle azioni della società, per un valore di ARS 10.20B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2 anni e 3 anni.

Informazioni chiave

Jason Hollar

Amministratore delegato

US$25.7m

Compenso totale

Percentuale dello stipendio del CEO	5.6%
Mandato del CEO	2.1yrs
Proprietà del CEO	0.008%
Durata media del management	2.1yrs
Durata media del Consiglio di amministrazione	3.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jason Hollar rispetto agli utili di Cardinal Health?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	US$26m	US$1m	US$852m
Mar 31 2024	n/a	n/a	US$552m
Dec 31 2023	n/a	n/a	US$639m
Sep 30 2023	n/a	n/a	US$156m
Jun 30 2023	US$19m	US$1m	US$330m
Mar 31 2023	n/a	n/a	US$463m
Dec 31 2022	n/a	n/a	-US$1b
Sep 30 2022	n/a	n/a	-US$1b
Jun 30 2022	US$4m	US$729k	-US$938m
Mar 31 2022	n/a	n/a	-US$955m
Dec 31 2021	n/a	n/a	US$555m
Sep 30 2021	n/a	n/a	US$1b
Jun 30 2021	US$4m	US$700k	US$611m
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	n/a	n/a	US$1b
Sep 30 2020	n/a	n/a	US$973m
Jun 30 2020	US$4m	US$124k	-US$4b

Compensazione vs Mercato: La retribuzione totale di Jason ($USD 18.78M ) è superiore alla media delle aziende di dimensioni simili nel mercato AR ($USD 6.09M ).

Compensazione vs guadagni: La retribuzione di Jason è aumentata di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Jason Hollar (51 yo)

2.1yrs

Mandato

US$25,650,709

Compensazione

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jason Hollar	CEO & Director	2.1yrs	US$25.65m	0.0075% ARS 2.0b
Aaron Alt	Chief Financial Officer	1.7yrs	US$6.84m	0.0013% ARS 334.7m
Jessica Mayer	Chief Legal & Compliance Officer	5.6yrs	US$4.66m	0.011% ARS 2.9b
Stephen Mason	Chief Executive Officer of Medical Segment	5.2yrs	US$7.34m	0% ARS 0
Deborah Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment	2.1yrs	US$5.09m	0.0083% ARS 2.2b
Mary Scherer	Senior VP & Chief Accounting Officer	2.1yrs	Nessun dato	0.0051% ARS 1.3b
Michelle Greene	Executive VP	2.2yrs	Nessun dato	0.0080% ARS 2.1b
Matt Sims	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Ola Snow	Chief Human Resources Officer	6yrs	Nessun dato	0.011% ARS 3.0b
Craig Cowman	Executive Vice President of Biopharma Solutions & Strategic Sourcing	no data	Nessun dato	Nessun dato
Patricia English	Senior Vice President	1.7yrs	US$1.26m	0.0020% ARS 541.9m
Ben Brinker	President of Global Products & Supply Chain	3.6yrs	Nessun dato	Nessun dato

2.1yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di CAH è considerato esperto (durata media dell'incarico 2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jason Hollar	CEO & Director	2.2yrs	US$25.65m	0.0075% ARS 2.0b
Gregory Kenny	Independent Non-Executive Chairman	17.2yrs	US$570.10k	0% ARS 0
Christine Ann Mundkur	Independent Director	2.1yrs	US$318.09k	0% ARS 0
Patricia Hemingway Hall	Independent Director	11.1yrs	US$338.09k	0.0045% ARS 1.2b
David Evans	Independent Director	4.3yrs	US$320.09k	0% ARS 0
Sheri Edison	Independent Director	4.1yrs	US$338.09k	0.0017% ARS 446.3m
Nancy Killefer	Independent Director	9.1yrs	US$330.61k	0% ARS 0
Akhil Johri	Independent Director	6.7yrs	US$345.09k	0% ARS 0
Sujatha Chandrasekaran	Independent Director	2.1yrs	US$320.09k	0% ARS 0
Steven Barg	Independent Director	2.1yrs	US$318.09k	0.0011% ARS 305.5m
Robert Azelby	Independent Director	less than a year	US$182.66k	0% ARS 0
Michelle Brennan	Independent Director	2.1yrs	US$318.09k	0.0014% ARS 363.9m

3.1yrs

Durata media

61yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CAH sono considerati esperti (durata media dell'incarico 3 anni).

Cardinal Health Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Cardinal Health, Inc Announces Executive Changes, Effective February 10, 2023

Cardinal Health, Inc., Annual General Meeting, Nov 09, 2022

Recent updates

Cardinal Health, Inc. to Report Q1, 2025 Results on Nov 01, 2024

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2024

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Cardinal Health, Inc. to Report Q4, 2024 Results on Aug 14, 2024

Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024

Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024

Cardinal Health, Inc. to Report Q3, 2024 Results on May 02, 2024

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024

Cardinal Health, Inc. (NYSE:CAH) entered into a definitive agreement to acquire Specialty Networks, LLC for $1.2 billion.

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2024

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2024

Cardinal Health Launches Smartgown™ Edge Breathable Surgical Gown with Assist™ Instrument Pockets

Cardinal Health Launches Kangaroo OMNI Enteral Feeding Pump

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Cardinal Health, Inc. to Report Q1, 2024 Results on Nov 03, 2023

Cardinal Health, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2023

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Cardinal Health, Inc. to Report Q4, 2023 Results on Aug 15, 2023

Cardinal Health, Inc. (NYSE:CAH) announces an Equity Buyback for $3,500 million worth of its shares.

Transaction Data Systems, Inc. agreed to acquire Outcomes business of Cardinal Health.

Cardinal Health Launches Modern Commerce Solutions for Retail Independent Pharmacies Powered by Square

Cardinal Health, Inc. Announces Quarterly Dividend, Payable on July 15, 2023

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on April 15, 2023

Cardinal Health, Inc. Revises Earnings Guidance for the Fiscal Year 2023

Cardinal Health, Inc. to Report Q2, 2023 Results on Feb 02, 2023

Cardinal Health, Inc Announces Executive Changes, Effective February 10, 2023

Cardinal Health Announces the Launch of Velocare

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2023

Cardinal Health, Inc., Annual General Meeting, Nov 09, 2022

Cardinal Health, Inc. to Report Q1, 2023 Results on Nov 04, 2022

Cardinal Health Announces Executive Changes

Cardinal Health, Inc. Announces Executive Appointments

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2022

Cardinal Health Appoints Michelle Greene as Chief Information Officer

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.

Cardinal Health, Inc.(NYSE:CAH) dropped from Russell 3000E Growth Index

Cardinal Health Approves Quarterly Dividend, Payable on July 15, 2022

Cardinal Health, Inc. to Report Q3, 2022 Results on May 05, 2022

AmerisourceBergen, Cardinal Health and McKesson Approve Opioid Settlement Agreement

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on April 15, 2022

Whistleblower Law Collaborative Clients' False Claims Act Suit Leads United States and States to Recover over 13 Million Dollars from Cardinal Health

AmerisourceBergen, Cardinal Health and McKesson Announce Settlement with Cherokee Nation

Hellman & Friedman LLC completed the acquisition of Cordis Corporation from Cardinal Health, Inc. (NYSE:CAH).

Cardinal Health Launches NavixRx Compliance Packaging and E-Commerce Storefront

Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2021

Cardinal Health Approves Quarterly Dividend, Payable on July 15, 2021

Cardinal Health Launches Outcomes™

Hellman & Friedman LLC signed a definitive agreement to acquire Cordis Corporation from Cardinal Health, Inc. (NYSE:CAH) for approximately $1 billion.

Cardinal Health Collaborates with HIMSS Analytics® as Certified Organization of New Cisom Maturity Model

Cardinal Health Launches TotalVue Analytics, A Logistics Management Tool Powered by Data to Drive Cost Savings

Cardinal Health, Inc. to Report Q2, 2021 Results on Feb 05, 2021

Ohio Chooses Cardinal Health for COVID-19 Vaccine Distribution

Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies

Cardinal Health, Inc. Announces Audit Committee Appointments

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione